Revenue

The Swiss watchmaker partners with the BTS star, leveraging the 'K-Pop effect' in a strategic move to redefine luxury for a new generation.

With over $10M in new funding, Berlin Heals is advancing a novel implant that uses a gentle electrical field to potentially reverse heart failure damage.

Aircraft leasing giant Avolon posts record profits, capitalizing on soaring travel demand and severe aircraft shortages plaguing global airlines.

Chinese industrial giant Weichai Group sweeps top green design awards, pushing diesel efficiency to record levels and challenging global industry norms.

The Norwegian drugmaker posted all-time high revenue and EBITDA for 2025, signaling resilience and a strategic pivot to future growth beyond metformin.

The baggage service giant renewed its Miami Airport contract until 2036, but can this unprecedented stability weather new tech and evolving travel trends?

The VR firm projects major growth, leveraging its subscription model and a key role in the global nuclear energy revival with its digital twin technology.

The vaccine maker posts record 2025 earnings on mpox demand but signals a strategic shift, prioritizing its travel vaccine portfolio over new R&D.

The clean fuel tech leader lands its first commercial aerospace order, leveraging its advanced carbon fiber composites for a demanding new frontier.

The Magnum Ice Cream Company's first year post-Unilever shows robust growth, but massive separation costs take a big bite out of profits.

The French biopharma giant posts strong 2025 results and forecasts over 13% growth, fueled by a booming pipeline and unexpected market advantages.

Estonian lender Bigbank AS taps private investors for a €3 million AT1 bond issuance, a strategic move to bolster its capital base amid ambitious growth plans.

Fox ESS battery owners can now join Origin's VPP, turning home storage into a revenue source while bolstering Australia's renewable energy grid.

LG's SKS brand enters the luxury laundry market and debuts new smart kitchen tech at KBIS 2026, aiming to dominate the integrated high-end home.

Nektar Therapeutics secures a massive $400M offering, signaling strong investor faith in its lead drug, rezpegaldesleukin, for autoimmune diseases.

Tokyo's premier creative festival returns, transforming nine districts with its 'FUTURE VINTAGE' theme, a new Vintage Fashion Week, and city-wide art.

Gabelli Multimedia Trust maintains its high-yield distribution after a blockbuster 2025, but what does its 21% 'cash on cash' payout really mean for investors?

Proem Acquisition Corp I launches a $130M IPO, led by tech IPO guru Imran Khan. But can it succeed in a revived, yet risk-laden, SPAC landscape?

The insurer's double-digit dividend hike follows a year of record core earnings, rewarding shareholders and showcasing its robust financial health.

The satellite firm unveils a complex debt shuffle and $1B capital raise, fueling its network vision while sending its stock tumbling on dilution fears.